FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments, today announced the appointment of Deni M. Zodda, Ph.D., to the position of Senior Vice President and Chief Business Officer. In addition, NovaDel announced the promotion of Frank Blondino, Ph.D., to the position of Executive Director, Formulation and Process Development.
